Skip to main content
SpringerLink
Log in

Access to Comprehensive Chagas Disease Care: A Global Effort

  • Chapter
  • First Online:
Chagas Disease

Abstract

The approval of a World Chagas Disease Day in 2019 at the 72nd World Health Assembly recognized Chagas disease as a global public health challenge. Chagas is one of the most neglected diseases and as such an important target to reach the third Sustainable Development Goal (SDG). Today, the majority of the affected population remains without access to life-saving health care.

We highlight the crucial role of three important players, starting with the people living with the disease or at risk of being infected. Secondly, we analyze how Chagas disease management must be addressed through each of the six components of the WHO health systems framework. And, finally, we tackle the need of innovation, starting from the improvement and expansion of the current diagnosis and treatment tools, and following with the need for new tools. We also summarize successful experiences in treating Chagas disease in some endemic and non-endemic countries thanks to the involvement of private foundations, health institutions, or NGOs in collaboration with public structures and other health system actors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pathmanathan I, Liljestrand J, Martins JM, Rajapaksa LC, Lissner C, de Silva A, Selvaraju S, Joginder Singh P. Investing in maternal health: learning from Malaysia and Sri Lanka (English). Health, nutrition, and population series. Washington, DC: World Bank; 2003. Available from: http://documents.worldbank.org/curated/en/367761468760748311/Investing-in-maternal-health-learning-from-Malaysia-and-Sri-Lanka.

    Google Scholar 

  2. Manne-Goehler J, Umeh CA, Montgomery SP, Wirtz VJ. Estimating the burden of Chagas disease in the United States. PLoS Negl Trop Dis. 2016;10(11):e0005033. https://doi.org/10.1371/journal.pntd.0005033.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Rovira B. “El mal de los pobres”. A vivir que son dos días. Cadena SER Radio. Uploaded 25/02/2017. Available from: https://cadenaser.com/programa/2017/02/24/a_vivir_que_son_dos_dias/1487954102_748040.html.

  4. Medecins Sans Frontieres, MSF. México: “Chagas: es hora de romper el silencio”. MSF México. 2009. Available from: https://www.msf.mx/article/chagas-es-hora-de-romper-el-silencio.

  5. WHO. Chagas’ disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec. 2015;90:33–40. Available from: http://www.who.int/wer/2015/wer9006.pdf?ua=1.

    Google Scholar 

  6. WHO. WHA63.20 resolution. “Chagas disease: control and elimination”. 63 World Health Assembly. Geneva: WHO; 2010. Available from: https://www.who.int/neglected_diseases/mediacentre/WHA_63.20_Eng.pdf?ua=1.

    Google Scholar 

  7. WHO. Accelerating work to overcome the global impact of neglected tropical diseases. A roadmap for implementation. Geneva: WHO Press; 2012. Available from: https://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf.

    Google Scholar 

  8. WHO. Chagas disease. In: WHO. Integrating neglected tropical diseases into global health and development: fourth WHO report on neglected tropical diseases. 5.2. Geneva: WHO; 2017. p. 155–62. Available from: https://www.who.int/neglected_diseases/resources/9789241565448/en/.

    Google Scholar 

  9. Costa Chaves G, Abi-Saab Arrieche M, Rode J, Mechali D, Ouverney Reis P, Vieira Alves R, et al. Estimación de la demanda de medicamentos antichagásicos: una contribución para el acceso en América Latina. Rev Panam Salud Publica. 2017;41:e45.

    PubMed Central  Google Scholar 

  10. Roddy P, Goiri J, Flevaud L, Palma P, Morote S, Lima N, Villa L, Torrico F, Albajar-Viñas P. Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood. J Clin Microbiol. 2008;46:2022–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2446863/.

    Article  Google Scholar 

  11. FDA. FDA approves first U.S. treatment for Chagas disease. 2017. Available from: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm573942.htm. Updated 27 Mar 2018.

  12. Moriana S, Ortiz G, Fanjul G. Breaking the silence: an opportunity for patients with Chagas. Chagas disease global coalition by creative commons. English online edition. 2016. Available from: http://www.coalicionchagas.org/documents/5415804/5524305/breaking+the+silence_report/65091404-85cf-4796-bebb-64c120a26216.

  13. DNDi. Ending the Neglect of Chagas. DNDi. 2018. Available from: https://www.dndi.org/2018/media-centre/news-views-stories/stories/visualstory/chagas-colombia/. Accessed 21 Jan 2019.

  14. Infochagas. Chagas coalition. How is it transmitted? Available from: http://www.infochagas.org/en/como-se-transmite. Accessed 21 Jan 2019.

  15. Federación Internacional de Asociaciones de Personas Afectadas por la Enfermedad Chagas. FINDECHAGAS. 2018. Available from: http://findechagas.org/. Accessed 22 Jan 2019.

  16. UNAIDS. Terminology guidelines. 2015. Available from: http://www.unaids.org/sites/default/files/media_asset/2015_terminology_guidelines_en.pdf. Accessed 22 Jan 2019.

  17. FDA (The U.S. Foods and Drug Administrations). The voice of the patient. Center for Drug Evaluation and Research (Chagas diseaseER) U.S. Food and Drug Administration (FDA). Report uploaded in November 2015. Available from: https://www.fda.gov/downloads/Drugs/NewsEvents/UCM474051.pdf. Accessed 23 Jan 2019.

  18. Doctors Without Borders (MSF). Chagas, a silent tragedy. Buenos Aires: Editorial Losada; 2005.

    Google Scholar 

  19. World Health Organization. Weekly epidemiological record - Chagas diseases in Latin America: an epidemiological update based on 2010 estimates. Geneva: WHO; 2015. p. 5–13.

    Google Scholar 

  20. Lee BY, Bacon KM, Bottazzi ME, Hotez PJ. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis. 2013;13:342–8.

    Article  Google Scholar 

  21. Villalba R, Fornes G, Alvarez MA, Roman I, Rubio V, Fernandez M, Garcia JM, Vinal M, Torres A. Acute Chagas’ disease in a recipient of a bone marrow transplant in Spain: case report. Clin Infect Dis. 1992;14:594–5.

    Article  CAS  Google Scholar 

  22. Navarro M, Navaza B, Guionnet A, López-Vélez R. Chagas disease in Spain: need for further public health measures. PLoS Negl Trop Dis. 2012;6(12):e1962. https://doi.org/10.1371/journal.pntd.0001962.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Hotez PJ, Dumonteil E, Betancourt Cravioto M, Bottazzi ME, Tapia-Conyer R, Meymandi S, et al. An unfolding tragedy of Chagas disease in North America. PLoS Negl Trop Dis. 2013;7(10). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814410/. Accessed 9 May 2018.

  24. Chagas Disease affects 300,000 people (and homeland security dogs) in U.S. Available from: https://www.idse.net/From-Zoo-to-You/Article/11-18/Chagas-Causing-Heart-Problems-in-Homeland-Security-Dogs/53321?sub=&enl=true.

  25. Alvarez MG, Bertocchi GL, Cooley G, Albareda MC, Viotti R, Perez-Mazliah DE, et al. Treatment success in Trypanosoma cruzi infection is predicted by early changes in serially monitored parasite- specific T and B cell responses. PLoS Negl Trop Dis. 2016;10(4). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851297/. Accessed 1 Apr 2018.

  26. Cucunubá ZM, et al. How universal is coverage and access to diagnosis and treatment for Chagas disease in Colombia? A health systems analysis. Soc Sci Med. 2017;175:187. https://doi.org/10.1016/j.socscimed.2017.01.002.

    Article  PubMed  Google Scholar 

  27. Ministerio de Salud Bolivia. Plan sectorial de desarrollo 2011-2015. 2009. Available from: https://www.minsalud.gob.bo/images/Documentacion/dgp/Plan_Sectorial_de_Desarrollo_2011- 2015_metas2020.pdf. Accessed 19 Apr 2018.

  28. Ministerio de Salud de Bolivia “La presencia del vector transmisor del Chagas en viviendas se redujo al 1,8% en Bolivia.” Available from: https://www.minsalud.gob.bo/3205-la-presencia-de-chagas-en-viviendas-se-redujo-al-1-8-en-bolivia. Accessed 18 Feb 2019.

  29. IDB. Inter-American Development Bank approves $45 million to improve health in Bolivia. Available from: https://www.iadb.org/en/news/news-releases/1999-02-10/idb-approves-45-million-to-improve-health-in-bolivia%2C1401.html. Accessed 25 May 2018.

  30. Day E, Hellard M, Treloar C, et al. On behalf of the International Network on Hepatitis in Substance Users (INHSU). Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework. Liver Int. 2019;39:20–30.

    Article  Google Scholar 

  31. PAHO WHO. Chagas disease. Available from: http://www.paho.org/hq/index.php?option=com_topics&view=article&id=10&Itemid=40743&lang=en. Accessed 17 Apr 2018.

  32. Marchiol A, Forsyth C, Bernal O, Valencia Hernández C, Cucunubá Z, Pachón Abril E, et al. Increasing access to comprehensive care for Chagas disease: development of a patient-centered model in Colombia. Rev Panam Salud Publica. 2017;41:e153. Available from: http://iris.paho.org/xmlui/handle/123456789/34506. Accessed 1 Apr 2018.

    PubMed  PubMed Central  Google Scholar 

  33. Gyapong JO, et al. Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities. Lancet. 2010;375:160–5.

    Article  Google Scholar 

  34. WHO. The world health report 2006 – working together for health. Geneva: WHO; 2006.

    Google Scholar 

  35. TDR Disease Reference Group on Chagas Disease, Human African Trypanosomiasis and Leishmaniasis, Weltgesundheitsorganisation. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis: technical report of the TDR Disease Reference Group on Chagas Disease, Human African Trypanosomiasis and Leishmaniasis. Geneva: World Health Organization; 2012. 100 p. (WHO technical report series).

    Google Scholar 

  36. Sales Junior PA, Molina I, Fonseca Murta SM, Sánchez-Montalvá A, Salvador F, Corrêa-Oliveira R, et al. Experimental and clinical treatment of Chagas disease: a review. Am J Trop Med Hyg. 2017;97(5):1289–303. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817734/. Accessed 8 Nov 2017.

    Article  CAS  Google Scholar 

  37. Brener Z, Cançado JR, Galvão LM, Da Luz ZM, Filardi LS, Pereira ME, Santos LM, Cançado CB. An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. Mem Inst Oswaldo Cruz. 1993;88:149–53.

    Article  CAS  Google Scholar 

  38. Chatelain E. Chagas disease research and development: is there light at the end of the tunnel? Comput Struct Biotechnol J. 2016;15:98–103. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5196238/. Accessed 18 Nov 2018.

    Article  Google Scholar 

  39. Pinazo M-J, Pinto J, Ortiz L, Sánchez J, García W, Saravia R, et al. A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: the Bolivian Chagas platform. PLoS Negl Trop Dis. 2017;11(8):e0005770.

    Article  Google Scholar 

  40. Sperandio da Silva GM, Mediano MFF, Hasslocher-Moreno AM, Holanda MT d, Silvestre de Sousa A, Sangenis LHC, et al. Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas’ disease. J Antimicrob Chemother. 2017;72(9):2596–601.

    Article  CAS  Google Scholar 

  41. Basile L, Oliveira I, Ciruela P, Plasencia A, Working group for developing the Ca collective. The current screening programme for congenital transmission of Chagas disease in Catalonia, Spain. Eurosurveillance. 2011;16(38). Available from: http://www.eurosurveillance.org/content/10.2807/ese.16.38.19972-en. Accessed 18 Nov 2018.

  42. Castillo-Riquelme M. Chagas disease in non-endemic countries. Lancet Glob Health. 2017;5(4):e379–80. Available from: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(17)30090-6/abstract. Accessed 18 Nov 2018.

    Article  Google Scholar 

  43. Meymandi S, Hernandez S, Park S, Sanchez DR, Forsyth C. Treatment of Chagas disease in the United States. Curr Treat Options Infect Dis. 2018;10(3):373–88. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132494/. Accessed 18 Nov 2018.

    Article  Google Scholar 

  44. Center of Excellence for Chagas Disease at Olive View UCLA Medical Center. 100&Change Solutions Bank. 100 and Change. Available from: http://100andchange.foundationcenter.org/profiles/811. Accessed 15 Nov 2018.

Download references

Author information

Authors and Affiliations

  1. Global Chagas Disease Coalition, Barcelona, Spain

    Francisco Javier Sancho

  2. University of Andes, Bogotá, Colombia

    Oscar Bernal

  3. Barcelona Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Barcelona, Spain

    Jeffrey V. Lazarus

Authors
  1. Francisco Javier Sancho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oscar Bernal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey V. Lazarus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francisco Javier Sancho .

Editor information

Editors and Affiliations

  1. Barcelona Institute for Global Health, Barcelona, Spain

    María-Jesús Pinazo Delgado

  2. Barcelona Institute for Global Health, Barcelona, Spain

    Joaquim Gascón

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sancho, F.J., Bernal, O., Lazarus, J.V. (2020). Access to Comprehensive Chagas Disease Care: A Global Effort. In: Pinazo Delgado, MJ., Gascón, J. (eds) Chagas Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-44054-1_12

Download citation

Publish with us

Policies and ethics

Search

Navigation